Immunodeficiency due to a classical component pathway complement deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

💰

4Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Immunodeficiency due to a classical component pathway complement deficiency.

Financial Assistance

4 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance4

TAKHZYRO

Takeda

OpenContact for detailsApply ↗

ACTIMMUNE

Horizon --- **Verification of current ownership:** Actimmune (interferon gamma-1b) is a biologic drug used to treat chronic granulomatous disease and malignant osteopetrosis. The rights to the drug we

OpenContact for detailsApply ↗

Kalbitor

Takeda

OpenContact for detailsApply ↗

VEOPOZ

Regeneron

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Immunodeficiency due to a classical component pathway complement deficiency.
Search all trials →

Search clinical trials for Immunodeficiency due to a classical component pathway complement deficiency →

Recent News & Research

No recent news articles indexed yet for Immunodeficiency due to a classical component pathway complement deficiency.
Search PubMed for Immunodeficiency due to a classical component pathway complement deficiency →

Browse all Immunodeficiency due to a classical component pathway complement deficiency news →

Specialist Network

No specialists currently listed for Immunodeficiency due to a classical component pathway complement deficiency.

View all Immunodeficiency due to a classical component pathway complement deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰